Skip to main content
OpenTrials

Clinical trial condition

Gastric Adenocarcinoma

Explore clinical trials studying Gastric Adenocarcinoma. Study availability and eligibility vary by location and protocol.

191 public trials 60 recruiting studies
Refine in advanced search Browse all conditions

Gastric Adenocarcinoma trial results

Completed

Adjuvant PIPAC in Gastric Cancer Patients

NCT04047004

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Adenocarcinoma, +7 more
Locations
  • Odense PIPAC Center, Department of Surgery, Odense University Hospital Odense, Denmark
  • Karolinska University Hospital Stockholm, Sweden
View Trial Details
Completed

A Study to Evaluate Rivoceranib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Participants With Gastric Cancer

NCT03042611

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Adenocarcinoma, +11 more
Locations
  • Mayo Clinic Phoenix Scottsdale, Arizona, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Mayo Clinic Cancer Center Rochester, Minnesota, United States
View all 95 locations
View Trial Details
Completed

A Study of Paclitaxel With or Without Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Cancer

NCT02898077

Conditions
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Locations
  • The Fifth Medical Center of PLA General Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
View all 32 locations
View Trial Details
Completed

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

NCT03365791

Conditions
Adenocarcinoma Of Esophagus, Advanced Well-differentiated Neuroendocrine Tumors, Bronchial Neoplasms, +28 more
Locations
  • California Pacific Medical Center Drug Shipment (2) San Francisco, California, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
  • University Cancer and Blood Center, LLC Athens, Georgia, United States
  • Northwestern University Medical School Chicago, Illinois, United States
View all 20 locations
View Trial Details
Completed

Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer

NCT01631552

Conditions
Adenocarcinoma, Adnexal Diseases, Astrocytoma, +78 more
Locations
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Helen F. Graham Cancer Center Newark, Delaware, United States
  • MD Anderson Cancer Center Orlando (UF Health Cancer Center) Orlando, Florida, United States
View Trial Details
Completed

A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer

NCT02082210

Conditions
Adenocarcinoma, Advanced Cancer, Bronchial Neoplasms, +31 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Tennessee Oncology PLLC Nashville, Tennessee, United States
View Trial Details

Related conditions